Developer - Bionaut Labs, Inc.
bionautlabs.com/technology
Printable View
Developer - Bionaut Labs, Inc.
bionautlabs.com/technology
https://vimeo.com/508242069
About Bionaut Labs
February 3, 2021
Quote:
Our vision is to revolutionize the treatment of CNS disorders.
By creating a new medical modality of remote-controlled micro-robots called Bionauts™ we can transform the way the biopharmaceutical industry develops treatments, allowing us to engineer the therapeutic index for efficacy and maintain safety.
https://vimeo.com/508486814
The Science Behind Bionaut Labs
Febryary 4, 2021
Quote:
A Bionaut™ is a new treatment modality that uses microscale robots to deliver biologics or small molecule therapies locally to targeted disease areas to help patients suffering from severe brain disorders.
Article "Are Bionauts™ a Vessel to the Final Frontier of CNS Diseases?"
by Heather McKenzie
March 3, 2021
"Bionaut Labs Debuts From Stealth Mode to Accelerate Development of New Precision Treatment Modality for Brain Disorders"
- First-in-class Bionaut™ treatment modality uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted brain disease areas
- $20M financing led by Khosla Ventures supports lead therapeutic program in glioma
- Safety and efficacy results in animals pave way for human clinical trials
March 3, 2021
"Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating Diseases"
Bionaut™ treatment platform deploys remote-controlled microscale robots capable of delivering therapies locally to inaccessible disease areas, including the midbrain
Funding supports pre-clinical and clinical research, expansion of clinical targets and progression through two accelerated FDA designations
November 28, 2022